Pintas & Mullins Law Firm

Blog Posts in April, 2005

  • FDA Warnings: All Show No Substance

    On April 7, 2005, the FDA required Pfizer to put a “black box” warning on Celebrex labels . This is the strongest warning available to the FDA, and requires doctors to prescribe Celebrex as a last resort for patients suffering from pain. The drug is also contraindicated for those post-coronary artery bypass surgery. This all sounds good, but the fact is that many doctors and patients will never ...
    Continue Reading
  • What in the H*** is a MDL?

    The withdrawal of Vioxx, and more recently Bextra, has created a hum of corporate irresponsibility and deception. Hundreds of Vioxx and an increasing number of Bextra lawsuits are filed . As these cases progress, you will here more and more on the topic of Multi District Litigation, or a “MDL.” Below is some helpful information on an MDL and its procedural workings. An MDL is an attempt to ...
    Continue Reading
  • Celebrex Receives Black Box Warning

    Blackbox Warnings Added to Celebrex Label On April 7, 2005, the FDA forced Pfizer to add its sternest warning for a medication. The "black box" warnings alert consumers of the serious cardiovascular risks such as heart attacks and strokes. Studies as far back as 1999 and as recent as December of 2004 link Celebrex with an increased risk of cardiovascular events. The FDA considered the findings of ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.